Copper Tripeptide-1 is a biomimetic peptide that works in harmony with skin, supporting collagen and elastin production, helping strengthen the skin barrier, and promoting visibly healthier, more resilient-looking skin
Other indications include malabsorption disorders (such as Crohn's disease or coeliac disease), following gastric surgery, strict vegan diets without supplementation, and certain medications that interfere with B12 absorption
The overall histologic pattern is often discohesive and infiltrative, in contrast to the confluent and expansile growth pattern of malignant melanoma
The recently published phase-3 clinical trials data of the drug donanemab, which targets amyloid plaque, have shown to reduce cognitive decline in AD patients, but also cause brain haemorrhage (bleeding) and edema (swelling) in some of these patients